Berlin - Delayed Quote EUR

Enzo Biochem Inc (EZB.BE)

0.6300

-0.0150

(-2.33%)

At close: January 14 at 8:08:26 AM GMT+1

Enzo Biochem Receives Notice of Non-Compliance with New York Stock Exchange Listing Rules

FARMINGDALE, N.Y, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced that it was notified by the New York Stock Exchange (the “NYSE”) that it is not in compliance with Section 802.01B and Section 802.01C of the NYSE Listed Company Manual because (i) its 30 trading-day average market capitalization was less than $50 million and its last reported stockholder’s equity as of October 31, 2024 was less than $50 million and (ii) the average closin

GlobeNewswire 7 hours ago

ENZ
ENZ Stock Falls Post Q1 Earnings Amid Revenue and Demand Challenges

Enzo Biochem reports a first-quarter fiscal 2025 quarterly loss and revenue drop across regions amid challenges in the life sciences tools market.

Zacks 26 days ago

ENZ

^GSPC
Enzo Biochem First Quarter 2025 Earnings: US$0.059 loss per share (vs US$0.11 loss in 1Q 2024)

Enzo Biochem ( NYSE:ENZ ) First Quarter 2025 Results Key Financial Results Revenue: US$6.21m (down 20% from 1Q 2024...

Simply Wall St. 27 days ago

ENZ
Enzo Biochem: Fiscal Q1 Earnings Snapshot

FARMINGDALE, N.Y. (AP) — Enzo Biochem Inc. ENZ) on Monday reported a loss of $3.4 million in its fiscal first quarter. On a per-share basis, the Farmingdale, New York-based company said it had a loss of 7 cents.

Associated Press Finance 29 days ago

ENZ
Enzo Biochem Reports First Quarter Fiscal Year 2025 Results and Provides a Company Update

FARMINGDALE, N.Y., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the fiscal first quarter ended October 31, 2024. First Quarter Highlights Enzo ended the first quarter with aggregate cash and cash equivalents of $47.7 million. The net cash used in operating activities during the first quarter decreased by $4.4 million compared to the prior year. The Company's first-quarter revenue of $6.2 million declined year-ove

GlobeNewswire 29 days ago

ENZ
The Zacks Analyst Blog Highlights Amgen, Eaton, Sony, iMage and Enzo Biochem

Amgen, Eaton, Sony, iMage and Enzo Biochem are included in this Analyst Blog.

Zacks last month

ETN

AMGN

ENZ
Top Stock Reports for Amgen, Eaton & Enzo Biochem

Today's Research Daily features new research reports on 16 major stocks, including Amgen Inc. (AMGN), Eaton Corp. plc (ETN) and Sony Group Corp. (SONY), as well as two micro-cap stocks, Moving iMage Technologies, Inc. (MITQ) and Enzo Biochem, Inc. (ENZ).

Zacks last month

AMGN

ENZ

ETN
US Penny Stocks To Watch In December 2024

As the U.S. market takes a breather from its post-election rally, major indices like the Dow Jones and S&P 500 are seeing slight declines while still riding high on recent record achievements. In this context, penny stocks—often smaller or newer companies—remain an intriguing investment area despite their somewhat outdated label. These stocks can offer unique growth opportunities, especially when backed by solid financials, making them worthy of attention for investors seeking under-the-radar...

Simply Wall St. last month

ENZ

ICAD

SYPR
We're Keeping An Eye On Enzo Biochem's (NYSE:ENZ) Cash Burn Rate

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Simply Wall St. 2 months ago

ENZ
Enzo Biochem Full Year 2024 Earnings: US$0.19 loss per share (vs US$0.51 loss in FY 2023)

Enzo Biochem ( NYSE:ENZ ) Full Year 2024 Results Key Financial Results Revenue: US$31.9m (up 2.7% from FY 2023). Net...

Simply Wall St. 2 months ago

ENZ
ENZ Stock Up Following FY24 Earnings Uptick, Gross Margin Expands

Enzo Biochem's overall topline benefits from revenue growth in the majority of its geographic regions.

Zacks 2 months ago

ENZ
Enzo Biochem Reports Fourth Quarter and Fiscal Year 2024 Results and Announces Cash Dividend

FARMINGDALE, N.Y., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the fiscal fourth quarter ended July 31, 2024 and the fiscal year ended July 31, 2024. The Company also announced that its board of directors had authorized a cash dividend of $0.10 per share of its common stock. Full Year Highlights The Company's revenues in the 2024 period of $31.9 million improved year-over-year by 3%. Enzo’s sales to its industri

GlobeNewswire 2 months ago

ENZ
Enzo Biochem to pay $4.5m for leaked healthcare data due to lax security

The personal data of 2.4 million patients was compromised due to poor security practices by Enzo Biochem.

Verdict 4 months ago

ENZ
Zacks Initiates Coverage of Enzo Biochem With Neutral Recommendation

Discover why Zacks rates Enzo Biochem as "Neutral", being the first on Wall Street to initiate coverage on the stock. Explore ENZ's notable revenue growth and financial health amid market challenges.

Zacks 6 months ago

ENZ
Enzo Biochem Third Quarter 2024 Earnings: US$0.042 loss per share (vs US$0.31 loss in 3Q 2023)

Enzo Biochem ( NYSE:ENZ ) Third Quarter 2024 Results Key Financial Results Revenue: US$8.02m (down 50% from 3Q 2023...

Simply Wall St. 6 months ago

ENZ
Enzo Biochem (ENZ) Q3 Earnings Improve Y/Y, Gross Margin Up

Enzo Biochem's (ENZ) overall topline benefits from revenue growth in the majority of its geographic regions.

Zacks 6 months ago

ENZ
Enzo Biochem Reports Third Quarter Fiscal 2024 Results and Provides Business Update

FARMINGDALE, N.Y., June 13, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the fiscal third quarter ended April 30, 2024. Third Quarter Highlights The Company's Life Science division's third-quarter revenue of $8.0 million improved year-over-year by 7%, marking four consecutive quarters of revenue growth compared to the prior year quarterly periods. Revenue for the nine months ended April 30, 2024 of $24.4 million improved

GlobeNewswire 6 months ago

ENZ
Enzo Biochem (NYSE:ENZ) shareholders have endured a 69% loss from investing in the stock three years ago

Investing in stocks inevitably means buying into some companies that perform poorly. But the long term shareholders of...

Simply Wall St. 9 months ago

ENZ
Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business Update

FARMINGDALE, N.Y., March 13, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the second quarter ended January 31, 2024. Second Quarter Highlights The Company's Life Science division's second-quarter revenue of $8.5 million improved year-over-year by 14%. During the 2024 period, we experienced a 25% revenue increase in the United States, driven by increased product demand in the drug development and cell and gene therapy mark

GlobeNewswire 9 months ago

ENZ
Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments

FARMINGDALE, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading life science company, announced the voting results from its Annual Meeting held on January 31, 2024 and officer appointments. Summary of the Fiscal Year 2023 Annual Shareholder Meeting Proposals Proposal One – The shareholders elected Kara Cannon, Steven J. Pully, Bradley L. Radoff, and Mary Tagliaferri, M.D. to the Company’s Board of Directors to hold office for a term ending a

GlobeNewswire 11 months ago

ENZ

Performance Overview

Return	EZB.BE	S&P 500
YTD	-7.35%	-1.08%
1-Year	-44.35%	+22.14%
3-Year	-75.16%	+25.41%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Enzo Biochem Inc (EZB.BE)

Enzo Biochem Receives Notice of Non-Compliance with New York Stock Exchange Listing Rules

ENZ Stock Falls Post Q1 Earnings Amid Revenue and Demand Challenges

Enzo Biochem First Quarter 2025 Earnings: US$0.059 loss per share (vs US$0.11 loss in 1Q 2024)

Enzo Biochem: Fiscal Q1 Earnings Snapshot

Enzo Biochem Reports First Quarter Fiscal Year 2025 Results and Provides a Company Update

The Zacks Analyst Blog Highlights Amgen, Eaton, Sony, iMage and Enzo Biochem

Top Stock Reports for Amgen, Eaton & Enzo Biochem

US Penny Stocks To Watch In December 2024

We're Keeping An Eye On Enzo Biochem's (NYSE:ENZ) Cash Burn Rate

Enzo Biochem Full Year 2024 Earnings: US$0.19 loss per share (vs US$0.51 loss in FY 2023)

ENZ Stock Up Following FY24 Earnings Uptick, Gross Margin Expands

Enzo Biochem Reports Fourth Quarter and Fiscal Year 2024 Results and Announces Cash Dividend

Enzo Biochem to pay $4.5m for leaked healthcare data due to lax security

Zacks Initiates Coverage of Enzo Biochem With Neutral Recommendation

Enzo Biochem Third Quarter 2024 Earnings: US$0.042 loss per share (vs US$0.31 loss in 3Q 2023)

Enzo Biochem (ENZ) Q3 Earnings Improve Y/Y, Gross Margin Up

Enzo Biochem Reports Third Quarter Fiscal 2024 Results and Provides Business Update

Enzo Biochem (NYSE:ENZ) shareholders have endured a 69% loss from investing in the stock three years ago

Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business Update

Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments

Performance Overview